STADA starts new chapter of growth in UK under Craig Shaw’s leadership

German generics and consumer healthcare major STADA Arzneimittel (SAZ: Xetra) has appointed Craig Shaw as its general manager in the UK.

Bringing over 25 years of senior leadership experience in the health and personal care industry, Mr Shaw held executive roles at leading organizations including Scholl’s Wellness as chief executive, Reckitt Benckiser, and Novartis Consumer Healthcare.

Peter Goldschmidt, chief executive of STADA, commented: “With the UK ranking among STADA’s five largest countries by revenues, accelerating UK growth organically and inorganically is a key strategic priority. We are, under Craig’s experienced leadership, embarking on a new chapter of growth in the UK, including by actively seeking attractive acquisition opportunities to strengthen our portfolio and pipeline of Consumer Healthcare, Generics and Specialty products.”